Interactive Brokers
IBKR
$83.79
+0.41%
Interactive Brokers Group, Inc. is a global automated electronic broker providing trading and clearing services for a wide range of financial products, including stocks, options, futures, forex, and bonds, operating within the investment banking and brokerage services industry. The company is a market leader distinguished by its sophisticated, low-cost trading platform, best-in-class order execution, and extremely low margin lending rates, catering primarily to a global clientele of sophisticated retail traders, hedge funds, and introducing brokers. The current investor narrative is driven by the company's direct benefit from increased trading activity during periods of market volatility, as highlighted in recent news, and its solid operational growth, though recent attention has also been tempered by a Q1 2026 revenue report that fell short of Wall Street expectations, creating a debate between its strong underlying business model and near-term financial performance.…
IBKR
Interactive Brokers
$83.79
Related headlines
Investment Opinion: Should I buy IBKR Today?
Rating & Thesis: Hold. IBKR is a high-quality company with a best-in-class model, but its stock price already reflects this excellence, trading at peak valuations after a powerful 68% annual rally, leaving limited near-term margin of safety.
Supporting Evidence: The stock trades at a forward P/E of 30.47x, a significant premium to industry peers. While Q4 2025 revenue grew 13.55% YoY and net income showed strong sequential growth, the recent Q1 2026 revenue miss indicates execution risk at these elevated levels. Profitability is stellar with an 87.52% operating margin, and the balance sheet is pristine with minimal debt. However, the technical picture shows the stock is overextended at 98.4% of its 52-week high.
Risks & Conditions: The two biggest risks are valuation compression and growth deceleration. This Hold rating would upgrade to a Buy if the PE multiple corrected meaningfully (e.g., below 25x) without a deterioration in the fundamental growth story, or if revenue growth re-accelerated above 15% consistently. It would downgrade to Sell if revenue growth decelerated below 10% or operating margins contracted significantly. Currently, the stock is overvalued relative to its history and industry, pricing in near-perfect execution.
Sign up to view all
IBKR 12-Month Price Forecast
The assessment is neutral based on a clash between stellar fundamentals and fully valued price. IBKR operates a superior, high-margin business with a fortress balance sheet, making it a compelling long-term holding. However, the current investment proposition is challenged by a valuation that prices in near-perfect execution and leaves little room for disappointment. The stance would upgrade to bullish on a meaningful pullback (10-15%) that improves the risk/reward profile, or on clear evidence of re-accelerating growth. It would turn bearish if the Q1 revenue miss signals the start of a sustained slowdown.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Interactive Brokers's 12-month outlook, with a consensus price target around $108.93 and implied upside of +30.0% versus the current price.
Average Target
$108.93
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$67 - $109
Analyst target range
Insufficient analyst coverage data is available to provide a meaningful consensus view, as the data indicates coverage from only one analyst. This limited coverage is atypical for a company of IBKR's market cap (~$111 billion) and suggests it may be under-followed by the broader sell-side community, which can lead to less efficient price discovery and higher volatility as news is incorporated into the price. The available data point shows a single analyst's estimated EPS for an unspecified period at $3.57, with a range from $3.44 to $3.75. The implications of minimal analyst coverage are significant: it often indicates the stock is not a staple in large institutional portfolios that require extensive research, or that its business model is considered niche or complex. For investors, this means conducting independent, thorough due diligence is paramount, as there is less aggregated professional opinion to rely upon. The recent institutional ratings from firms like Barclays and BMO Capital, which have maintained 'Overweight' or 'Outperform' ratings, provide some positive sentiment, but the lack of a broad consensus target price and distribution makes gauging Wall Street's overall stance challenging.
Bulls vs Bears: IBKR Investment Factors
The evidence currently leans bullish, underpinned by IBKR's demonstrably superior business model, exceptional profitability, strong operational growth, and pristine financials. However, the bear case is formidable, anchored entirely in valuation risk. The single most important tension in the investment debate is whether IBKR's premium valuation (~30x P/E) is justified by its ability to sustain high-teens revenue growth and maintain its extraordinary margins, or if it represents an overextended multiple vulnerable to compression on any growth disappointment. The recent Q1 revenue miss is a stark warning shot on this front.
Bullish
- Exceptional Profitability & Margins: IBKR's operating margin of 87.52% and gross margin of 91.12% in Q4 2025 are far above industry norms, reflecting its highly scalable, automated platform. This structural advantage drives superior returns on equity of 18.35% and massive free cash flow generation of $15.7 billion TTM.
- Powerful Revenue & Earnings Momentum: Revenue grew 13.55% YoY in Q4 2025 to $2.749B, with a clear sequential uptrend from $2.31B in Q1 2025. Net income grew from $213M to $284M over the same period, demonstrating strong operational leverage and consistent execution.
- Fortress Balance Sheet & Cash Flow: The company has a negligible debt-to-equity ratio of 0.0035 and a current ratio of 1.13, indicating minimal financial risk. Its TTM free cash flow of $15.7B provides immense strategic flexibility for growth, dividends, or buybacks.
- Strong Technical & Relative Outperformance: The stock is up 68.12% over the past year, significantly outperforming the SPY's 25.19% gain, and trades at 98.4% of its 52-week high, reflecting sustained bullish momentum. It has also shown strong relative strength over 1-month (9.17% vs SPY 5.6%) and 3-month (16.39% vs SPY 8.42%) periods.
Bearish
- Premium Valuation at Peak Multiples: IBKR trades at a trailing PE of 29.11x and a forward PE of 30.47x, a significant premium to typical brokerage industry multiples (mid-teens to low-20s). Its own historical PE has expanded from 17.14x in Q1 2024 to this peak level, leaving little room for error.
- Recent Revenue Miss & High Expectations: Recent news indicates Q1 2026 revenue fell short of Wall Street expectations, causing the stock to slip. This highlights the risk of the stock's premium valuation being vulnerable to any deceleration in its impressive growth trajectory.
- High Volatility & Extended Technicals: With a beta of 1.322, IBKR is 32% more volatile than the market, implying larger potential downside swings. Trading at 98.4% of its 52-week high after a 68% annual run suggests the stock is overextended and sensitive to negative catalysts.
- Limited Analyst Coverage & Visibility: The stock has coverage from only one analyst, which is atypical for its ~$111B market cap. This lack of broad sell-side research can lead to less efficient price discovery and higher volatility, making it harder to gauge consensus expectations.
IBKR Technical Analysis
The stock is in a sustained and powerful uptrend, having gained 68.12% over the past year, significantly outperforming the SPY's 25.19% gain. With a current price of $87.00, it is trading at 98.4% of its 52-week high of $88.44, indicating it is at the very top of its recent range, which reflects strong momentum but also suggests the potential for overextension and increased sensitivity to any negative catalysts. The short-term momentum remains robust and consistent with the longer-term trend, with the stock up 9.17% over the past month and 16.39% over the past three months, both figures handily outpacing the broader market's gains of 5.6% and 8.42%, respectively, signaling continued buying pressure and no immediate signs of a major reversal. Key technical support is anchored at the 52-week low of $49.15, though more immediate support likely resides near the recent consolidation zone in the low $70s, while the primary resistance is the 52-week high of $88.44. A decisive breakout above this level would signal a continuation of the powerful bull trend, whereas a failure and reversal could indicate a near-term top is forming. The stock's beta of 1.322 indicates it is approximately 32% more volatile than the SPY, which is material for risk management as it suggests the stock will experience larger swings in both directions relative to the overall market, a characteristic typical of high-momentum financial names.
Beta
1.32
1.32x market volatility
Max Drawdown
-18.8%
Largest decline past year
52-Week Range
$49-$88
Price range past year
Annual Return
+59.3%
Cumulative gain past year
| Period | IBKR Return | S&P 500 |
|---|---|---|
| 1m | +3.1% | +4.6% |
| 3m | +13.2% | +8.3% |
| 6m | +37.2% | +12.5% |
| 1y | +59.3% | +25.0% |
| ytd | +24.6% | +8.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
IBKR Fundamental Analysis
The company's revenue trajectory is one of solid growth, with Q4 2025 revenue reaching $2.749 billion, representing a 13.55% year-over-year increase. Examining the quarterly progression from Q1 2025 ($2.31B) to Q4 2025 ($2.749B) shows a consistent sequential uptrend, indicating accelerating business momentum through the year, which supports the investment case for a company capitalizing on active markets. The revenue segment data highlights that Commissions, at $582 million for the period, are the largest identifiable revenue stream, though the data lacks a full breakout to definitively identify the primary growth driver. Profitability is strong and margins are exceptionally high for a brokerage, with Q4 2025 net income of $284 million and a gross margin of 91.12%. The net margin for the quarter was 10.33%, and the operating margin was an impressive 87.52%, levels that are far above industry norms and reflect the company's highly automated, scalable platform. Profitability has been stable to improving, with net income growing from $213 million in Q1 2025 to $284 million in Q4 2025, demonstrating effective operational leverage. The balance sheet is exceptionally strong with minimal financial risk, evidenced by a minuscule debt-to-equity ratio of 0.0035. Liquidity is solid with a current ratio of 1.13. Most impressively, the company is a massive generator of free cash flow, with TTM free cash flow of $15.744 billion, providing immense internal funding capacity for growth, dividends, or share repurchases. The return on equity (ROE) of 18.35% is healthy and indicates efficient use of shareholder capital.
Quarterly Revenue
$2.7B
2025-12
Revenue YoY Growth
+0.13%
YoY Comparison
Gross Margin
+0.91%
Latest Quarter
Free Cash Flow
$15.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is IBKR Overvalued?
Given the company's consistent profitability with positive net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing twelve-month PE ratio is 29.11x, while the forward PE is slightly higher at 30.47x; this small premium suggests the market expects earnings growth to continue, albeit at a measured pace, and is not pricing in significant multiple expansion. Compared to typical industry averages for brokerage/investment services (which often range in the mid-teens to low-20s PE), IBKR's multiple of ~30x represents a significant premium. This premium is likely justified by the company's superior, technology-driven business model, exceptional operating margins near 86%, and its status as a global leader in electronic brokerage, which commands a growth multiple unlike traditional brokers. Historically, the stock's own valuation has expanded considerably. The current trailing PE of 29.11x is above its recent historical range, as seen in the quarterly data where the PE ratio has climbed from 17.14x in Q1 2024 to 25.21x in Q4 2025. Trading near the top of its own historical valuation band suggests the market is pricing in very optimistic expectations for sustained growth and profitability, leaving little room for operational missteps.
PE
29.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 14x~36x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: IBKR's primary financial risk is not leverage or liquidity—its balance sheet is a fortress—but rather its dependence on continued high growth to justify its premium valuation. A deceleration from the recent 13.55% YoY revenue growth rate could trigger significant multiple compression. Furthermore, while margins are currently exceptional at ~87% operating margin, any material increase in technology or compliance costs could pressure profitability. The company's revenue, while diversified across products, is fundamentally tied to the cyclicality of global trading volumes, introducing earnings volatility.
Market & Competitive Risks: The paramount risk is valuation compression. Trading at a forward P/E of 30.47x, IBKR commands a large premium to both its industry and its own historical range (17.14x in early 2024). A shift in market sentiment away from growth or a rise in interest rates could compress this multiple. Competitive risks are ongoing from both traditional brokers and fintech disruptors, though IBKR's low-cost, technology-led model provides a strong moat. The stock's high beta of 1.322 confirms its sensitivity to broader market swings, amplifying downside during corrections.
Worst-Case Scenario: The worst-case involves a combination of declining market volatility reducing trading commissions, rising costs eroding the stellar 87% operating margin, and a broader market sell-off triggering a derating of its premium multiple. This could see the stock re-test its 52-week low of $49.15, representing a potential downside of approximately -43% from the current price of $87. A more realistic severe bear case might see a pullback to the low-$70s support zone (a -15% to -20% decline), driven by an earnings miss and multiple contraction towards its historical average.
FAQ
The key risks are: 1) Valuation Risk: The primary risk is multiple compression from its peak ~30x P/E if growth decelerates. 2) Cyclical Risk: Revenue is tied to trading volumes and market volatility, which are inherently cyclical. 3) Execution Risk: The recent Q1 2026 revenue miss demonstrates the company is not immune to quarterly stumbles. 4) Volatility Risk: With a beta of 1.322, the stock is 32% more volatile than the market, leading to larger price swings. The valuation risk is currently the most severe given the stock's extended price.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock consolidating between $75 and $90 as growth moderates and the valuation digests its recent run. The Bull Case (25% probability) targets $95-$105 on sustained high growth and margin strength. The Bear Case (15% probability) sees a correction to $60-$72 on growth disappointment and multiple compression. The Base Case is most likely, implying limited near-term upside from the current $87 price, with the potential for volatility and a trading range.
IBKR stock is overvalued relative to its historical range and industry peers. Its forward P/E of 30.47x is significantly higher than typical brokerage multiples (mid-teens to low-20s) and represents a expansion from its own historical P/E of 17.14x in early 2024. The market is pricing in expectations of sustained high-teens growth and maintenance of extraordinary profitability. Any stumble in growth or margins would likely cause this premium to contract, posing a key downside risk.
IBKR is a good stock for investors seeking a high-quality, growing financial technology company, but it is not a good buy at the current moment. The stock has rallied 68% in the past year and trades at a premium forward P/E of 30.47x, leaving limited margin of safety. While the underlying business is exceptional with 87.5% operating margins and strong cash flow, the recent Q1 revenue miss highlights the risks at this valuation. It would become a more compelling buy on a pullback towards the $75-$80 range for long-term investors.
IBKR is more suitable for a long-term investment horizon of 3-5 years. While its high beta (1.322) creates short-term trading opportunities, the core investment thesis is based on the company's durable competitive advantages, scalable platform, and long-term market share gains. Short-term trading is risky due to the stock's volatility and current extended technical position. Long-term investors can better weather the inevitable cyclical downturns and benefit from the company's compounding cash flows and growth. A minimum holding period of 2-3 years is recommended to allow the fundamental story to play out.